PFGIA
AKTX

Patriot Financial Group Insurance Agency’s Akari Therapeutics AKTX Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1
Closed -$2K – 1664
2020
Q2 		$2K Hold
1
– – ﹤0.01% 1362
2020
Q1 		$1K Buy
+1
New +$1.39K ﹤0.01% 1380

Other funds holding AKTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OFW
Omnia Family Wealth Aventura, Florida $373M AUM 25.3% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Patriot Financial Group Insurance Agency's AKTX Position: Q3 2020 in Review

Patriot Financial Group Insurance Agency sold out of Akari Therapeutics (AKTX) in Q3 2020, closing a stake of 1 share — an estimated $2K sold.

Patriot Financial Group Insurance Agency first reported a position in AKTX in Q1 2020 and held it in 2 quarters. The position peaked at $2K in Q2 2020. 12 funds tracked by Wall St. Rank hold AKTX as of Q3 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Akari Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 1 Akari Therapeutics share in Q3 2020, an estimated $2K.
  • Patriot Financial Group Insurance Agency first reported a position in Akari Therapeutics in Q1 2020 and held it in 2 quarters.
  • Patriot Financial Group Insurance Agency's Akari Therapeutics position peaked at $2K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Akari Therapeutics as of Q3 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2020, filed 21 Oct 2020.